fda tirzepatide shortage update today says is over after taking a second look FDA Announced Removal of Tirzepatide

This summary provides basic information about Zepbound but does not include all information known about this medicine

The Nuanced Science of Subcutaneous Delivery To really appreciate why subcutaneous is the go-to route, we need to look a bit closer at the physiology

Many patients achieve their blood sugar and weight-loss goals at doses below 15 mg, such as 5 mg, 7.5 mg, or 10 mg weekly

Other potential side effects can include: Diarrhea Constipation Abdominal (stomach) pain Headache Fatigue Dyspepsia (indigestion) Dizziness Abdominal distension Eructation or belching Hypoglycemia (low blood sugar) in patients with type 2 diabetes Flatulence Gastroenteritis (an intestinal infection) Gastroesophageal reflux disease (a type of digestive disorder)